Organisation paid for research Program year 2025 Source: CMS Open Payments

Mplusm Consulting

Neither a doctor nor a teaching hospital

Research payments

$437,398

67 payments

Through program year 2025, Mplusm Consulting is reported as receiving $437,398 in research payments, across 67 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$19,443	5
2024	Research	$54,352	16
2023	Research	$138,103	24
2022	Research	$197,445	18
2021	Research	$4,611	2
2020	Research	$23,445	2

Breakdown

Who paid Research payments · program years 2020–2025

VIVUS, Inc. $227,625 11 payments
GlaxoSmithKline, LLC. $209,773 56 payments

Studies the money was for Research payments · program years 2020–2025

A Multi-Center, Randomized, Double-Blind, Parallel-Group, Placebo-Cont $181,718 52 payments
A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subject $144,945 3 payments
A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subject $82,680 8 payments
A Multicentre Randomized, Double-Blind, Placebo-Controlled Phase 2 Stu $28,056 4 payments

What the money was spent on Research payments · program years 2020–2025

Other $227,625 11 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.